IL1B and neoplasm: More aspects linked to the IL1 pathway have so far been described in UCB, such as IL1B-induced cisplatin-resistance by up-regulation of Aldo-keto reductase 1C1 [24], IL1 dependent intra-tumoral androgen receptor (AR) signaling, T-cell attraction, and recruitment of tumor-associated fibroblasts [26].